• Japanese
  • Korean
  • Chinese
Home > Publishers > La Merie Publishing
Publisher
Publisher

La Merie Publishing Report List

La Merie Business Intelligence was established in 2002 by Ulrich Martin, MD, based on his extensive experience in the biopharmaceutical industry both as a physician specializing in pharmacology and as a co-founder and CEO of a product development biotech company. The focus of our reports and subscription services such as databases and periodicals is directed towards biologs as therapeutics, such as antibodies, proteins, peptides, vaccines and biosimilars. Today we continue to publish reports, but leverage our experience, knowledge and report writing expertise to offer this service to individual customers.

Filter
Title Search
1 - 24 of 24 Products
Sort by
Display
Competitor Analysis: Therapeutic Antibodies 2015 - Biosimilars & Biosuperiors
Published by
La Merie Publishing
Price
USD 1500
Content info
414 Pages
Sample available
Engineered TCR and CAR Immunotherapeutics 2015
Published by
La Merie Publishing
Price
USD 2630
Content info
201 Pages
Sample available
Recombinant Coagulation Factors 2015: Maturation of Recombinant Clotting Factor Pipeline and Emergence of Gene Therapy and Alternative Procoagulants
Published by
La Merie Publishing
Price
USD 2795
Content info
210 Pages
Sample available
*
Published by
La Merie Publishing
Price
USD 1000
Content info
 
Sample available
Botulinum Neurotoxins: A Comparative Industry Analysis of Products, Pipelines, Technologies and Stakeholders
Published by
La Merie Publishing
Price
USD 2459
Content info
169 Pages
Sample available
Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies 2014
Published by
La Merie Publishing
Price
USD 1387
Content info
386 Pages
Sample available
*
Published by
La Merie Publishing
Price
USD 419
Content info
70 Pages
Sample available
Antibody-Drug Conjugates 2014: A Business, Technology & Pipeline Analysis
Published by
La Merie Publishing
Price
USD 2711
Content info
347 Pages
Sample available
The Engineered T-Cell Receptor in Fusion Proteins, Antibodies & Cells: Emerging Opportunities for the Biopharmaceutical Industry
Published by
La Merie Publishing
Price
USD 1829
Content info
84 Pages
Sample available
*
Published by
La Merie Publishing
Price
USD 7565
Content info
 
Sample available
*
Published by
La Merie Publishing
Price
USD 1513
Content info
 
Sample available
This report provides online access to more than 1,700 project entries for therapeutic proteins on the market and in research & development....
*
Published by
La Merie Publishing
Price
USD 1639
Content info
 
Sample available
*
Published by
La Merie Publishing
Price
USD 7565
Content info
 
Sample available
Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors
Published by
La Merie Publishing
Price
USD 2018
Content info
301 Pages
Sample available
This report includes a compilation of current active projects in research and development of biosimilar and novel biobetter/biosuperior therapeutic proteins....
Influence of Antibody Attributes on Clinical Success - A Technology and Coporate Benchmark Analysis
Published by
La Merie Publishing
Price
USD 1135
Content info
88 Pages
Sample available
Antibody Technologies and Attrition Rates - An Industry Analysis 2013
Published by
La Merie Publishing
Price
USD 2711
Content info
607 Pages
Sample available
Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists - A Target Pipeline and Stakeholder Analysis 2012
Published by
La Merie Publishing
Price
USD 2459
Content info
231 Pages
Sample available
Competitor Analysis: Anti-Infective Antibodies
Published by
La Merie Publishing
Price
USD 505
Content info
160 Pages
Sample available
The report includes a compilation of product portfolios and current active projects in research and development of anti-infective antibodies and immunoglobulins....
Coagulation Factors 2011 - Who Does Meet the Market Needs? A Pipeline Assessment, Market Survey and Corporate Benchmark Analysis
Published by
La Merie Publishing
Price
USD 2421
Content info
162 Pages
Sample available
*
Published by
La Merie Publishing
Price
USD 1261
Content info
 
Sample available
Subscription to La Merie' s proprietary Vaccine Pipeline Database provides online access to more than 1,200 project entries for prophylactic and therapeutic vaccines on the market and in research & development. Each project is specified for its Target or ...
Antibody-Drug Conjugates 2011 - Real Breakthrough Still to Come: A Technology, Stakeholder and R&D Pipeline Analysis
Published by
La Merie Publishing
Price
USD 1967
Content info
274 Pages
Sample available
The recent approval of Seattle Genetics' antibody-drug conjugate Adcetris has raised great enthusiasm among stakeholders in this field....
Competitor Analysis: Targeted Therapy of Diabetes
Published by
La Merie Publishing
Price
USD 1513
Content info
114 Pages
Sample available
The present Competitive Intelligence Report about Targeted Therapy of Diabetes provides a competitor evaluation in the field of novel molecules being developed for treatment of type 1 and 2 diabetes....
Competitor Analysis: Cancer Antibodies in Early Clinical Development
Published by
La Merie Publishing
Price
USD 1135
Content info
183 Pages
Sample available
The report includes a compilation of currently active projects in early clinical research and development of antibody therapeutic for treatment of cancer....
*
Published by
La Merie Publishing
Price
USD 5043
Content info
1 Year Access to All Reports
Sample available
Back to Top